Documents
Application Sponsors
ANDA 076336 | ACTAVIS LABS FL INC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Discontinued | 003 |
Application Products
001 | TABLET;ORAL | 15MG | 0 | MIRTAZAPINE | MIRTAZAPINE |
002 | TABLET;ORAL | 30MG | 0 | MIRTAZAPINE | MIRTAZAPINE |
003 | TABLET;ORAL | 45MG | 0 | MIRTAZAPINE | MIRTAZAPINE |
FDA Submissions
| ORIG | 1 | AP | 2003-06-20 | |
LABELING; Labeling | SUPPL | 3 | AP | 2005-04-28 | |
LABELING; Labeling | SUPPL | 5 | AP | 2005-04-28 | |
LABELING; Labeling | SUPPL | 6 | AP | 2006-11-06 | |
LABELING; Labeling | SUPPL | 7 | AP | 2007-11-05 | |
CDER Filings
ACTAVIS LABS FL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 76336
[companyName] => ACTAVIS LABS FL INC
[docInserts] => ["",""]
[products] => [{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"MIRTAZAPINE","activeIngredients":"MIRTAZAPINE","strength":"45MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"MIRTAZAPINE","submission":"MIRTAZAPINE","actionType":"15MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"MIRTAZAPINE","submission":"MIRTAZAPINE","actionType":"30MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"MIRTAZAPINE","submission":"MIRTAZAPINE","actionType":"45MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)